banner
IKK/IκB inhibitor TPCA-1, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ759

IKK/IκB inhibitor TPCA-1, Purity ≥98%

Synonym: TPCA-1; 507475-17-4; 5-(4-Fluorophenyl)-2-ureidothiophene-3-carboxamide; IKK-2 Inhibitor IV; TPCA1; 2-(Carbamoylamino)-5-(4-fluorophenyl)thiophene-3-carboxamide; [5-(p-Fluorophenyl)-2-ureido]thiophene-3-carboxamide; IKK/IκB inhibitor

  • MDL: MFCD09037541
  • CAS Number: 507475-17-4
  • Compound CID: 9903786
img
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
TPCA-1, soluble in DMSO and insoluble in ethanol and water, modulates IKK-IκB signaling pathway, which plays a key role in inflammation and immune responses. It targets IKK2.
Molecular Weight
279.29
Molecular Formula
C12H10FN3O2S
Targets
IKK2: 17.9 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 49 mg/mL (175.44 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
TPCA-1 can be used to explore its specific inhibitory effects on IKK-β in the NF-κB signaling pathway in inflammatory diseases and cancer research.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0